Interaction databaseSupplement × PrescriptionReviewed May 2026

Acyclovir and L-Lysine, a synergy.

L-lysine is used by some patients as adjunctive prophylaxis against herpes simplex recurrences, working by a different mechanism than acyclovir. Evidence is mixed and modest, but daily doses above 1-3 g have shown subjective benefit in some trials, with no known pharmacokinetic interaction with acyclovir or valacyclovir.

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances
Acyclovir and L-Lysine
Pair type
Synergy
Evidence (highest tier)
Emerging
Source citations
2 sources
Stack Score effect
+2 to your Stack Score (per scored synergy row).
Scope
Supplement × Prescription
Last verified
May 30, 2026

Synergy · Emerging evidence

Synergy

What is happening. L-lysine is used by some patients as adjunctive prophylaxis against herpes simplex recurrences, working by a different mechanism than acyclovir. Evidence is mixed and modest, but daily doses above 1-3 g have shown subjective benefit in some trials, with no known pharmacokinetic interaction with acyclovir or valacyclovir.

Mechanism. HSV replication depends on arginine for capsid protein synthesis; lysine competes with arginine for intestinal transport and renal reabsorption, potentially lowering intracellular arginine availability. Acyclovir, in contrast, inhibits viral DNA polymerase, so the mechanisms are non-overlapping.

Recommendation. Lysine is reasonable as a complement to acyclovir for recurrent oral or genital HSV, typically at 1-3 g per day. Do not use it as a substitute for prescribed antivirals during an active outbreak.

Sources (2)
  1. Mailoo VJ, Rampes S. Lysine for herpes simplex prophylaxis: a review of the evidence. Integr Med (Encinitas). 2017;16(3):42-46. PMID 30881246
  2. Griffith RS, et al. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Dermatologica. 1987;175(4):183-90. PMID 3115841

Stack Score

How this pair moves the number.

Effect on the composite score

If both Acyclovir and L-Lysine are in the same stack, this pair applies +2 to your Stack Score (per scored synergy row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.